Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · IEX Real-Time Price · USD
4.500
+1.100 (32.35%)
At close: Mar 28, 2024, 3:59 PM
4.300
-0.200 (-4.44%)
After-hours: Mar 28, 2024, 7:57 PM EDT

RGC Income Statement

Millions USD. Fiscal year is Jul - Jun.
Year 20232022202120202019
Selling, General & Admin
4.695.110.940.430.16
Research & Development
1.582.510.440.390.23
Operating Expenses
6.277.621.380.810.39
Operating Income
-6.27-7.62-1.38-0.81-0.39
Other Expense / Income
-0.4-0.17-0.03--
Pretax Income
-5.87-7.45-1.35-0.81-0.39
Net Income
-5.87-7.45-1.35-0.81-0.39
Shares Outstanding (Basic)
1313101010
Shares Outstanding (Diluted)
1313101010
Shares Change
1.62%28.06%---
EPS (Basic)
-0.45-0.58-0.13-0.08-0.04
EPS (Diluted)
-0.45-0.58-0.13-0.08-0.04
Free Cash Flow
-4.99-6.05-0.77-0.84-0.39
Free Cash Flow Per Share
-0.38-0.47-0.08-0.08-0.04
EBITDA
-5.1-6.84-1.32-0.8-0.39
Depreciation & Amortization
0.770.60.030.010
EBIT
-5.87-7.45-1.35-0.81-0.39
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).